WO2011058558A3 - Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state - Google Patents

Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state Download PDF

Info

Publication number
WO2011058558A3
WO2011058558A3 PCT/IL2010/000937 IL2010000937W WO2011058558A3 WO 2011058558 A3 WO2011058558 A3 WO 2011058558A3 IL 2010000937 W IL2010000937 W IL 2010000937W WO 2011058558 A3 WO2011058558 A3 WO 2011058558A3
Authority
WO
WIPO (PCT)
Prior art keywords
pluripotent stem
stem cells
methods
undifferentiated state
cells
Prior art date
Application number
PCT/IL2010/000937
Other languages
French (fr)
Other versions
WO2011058558A2 (en
Inventor
Michal Amit
Joseph Itskovitz-Eldor
Original Assignee
Technion Research & Development Foundation Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to EP22185625.5A priority Critical patent/EP4166652A1/en
Priority to EP10829622.9A priority patent/EP2499236B1/en
Priority to JP2012538468A priority patent/JP6276918B2/en
Priority to ES10829622T priority patent/ES2779048T3/en
Application filed by Technion Research & Development Foundation Ltd. filed Critical Technion Research & Development Foundation Ltd.
Priority to DK10829622.9T priority patent/DK2499236T3/en
Priority to EP19210132.7A priority patent/EP3633025B1/en
Priority to CA2783437A priority patent/CA2783437C/en
Priority to US13/508,991 priority patent/US9018010B2/en
Publication of WO2011058558A2 publication Critical patent/WO2011058558A2/en
Publication of WO2011058558A3 publication Critical patent/WO2011058558A3/en
Priority to IL219736A priority patent/IL219736A/en
Priority to US14/696,520 priority patent/US10876094B2/en
Priority to IL252607A priority patent/IL252607B/en
Priority to US17/097,023 priority patent/US20210079342A1/en
Priority to US17/841,700 priority patent/US20220333066A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/90—Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/92—Medium free of human- or animal-derived components
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/98—Xeno-free medium and culture conditions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/99—Serum-free medium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/45—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from artificially induced pluripotent stem cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Transplantation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

Provided are serum-free culture media which comprise basic fibroblast growth factor (bFGF), transforming growth factor beta-3, ascorbic acid, xeno-free serum replacement and a lipid mixture, the media may also compris an IL6R/IL6 chimera, or leukemia inhibitory factor (LIF); wherein the culture medium is capable of maintaining pluripotent stem cells in an undifferentiated state in the absence of feeder cell support. Also provided are cell cultures comprising pluripotent stem cells such as human embryonic stem cells and induced pluripotent stem (iPS) cells.and methods of using the same for expanding pluripotent stem cells in an undifferentiated state using two-dimensional or three-dimensional culture systems. Methods of expanding iPS cells in a suspension culture devoid of substrate adherence and cell encapsulation are also provided.
PCT/IL2010/000937 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state WO2011058558A2 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
EP19210132.7A EP3633025B1 (en) 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
JP2012538468A JP6276918B2 (en) 2009-11-12 2010-11-11 Medium, cell culture and method for culturing pluripotent stem cells in undifferentiated state
ES10829622T ES2779048T3 (en) 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
US13/508,991 US9018010B2 (en) 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
DK10829622.9T DK2499236T3 (en) 2009-11-12 2010-11-11 CULTURAL MEDIA, CELL CULTURES AND METHODS FOR CULTIVATING PLURIPOTENT STEM CELLS IN AN UNDIFFERENTIAL CONDITION
EP10829622.9A EP2499236B1 (en) 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
CA2783437A CA2783437C (en) 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
EP22185625.5A EP4166652A1 (en) 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
IL219736A IL219736A (en) 2009-11-12 2012-05-10 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
US14/696,520 US10876094B2 (en) 2009-11-12 2015-04-27 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
IL252607A IL252607B (en) 2009-11-12 2017-06-01 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
US17/097,023 US20210079342A1 (en) 2009-11-12 2020-11-13 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
US17/841,700 US20220333066A1 (en) 2009-11-12 2022-06-16 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27286009P 2009-11-12 2009-11-12
US61/272,860 2009-11-12

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US13/508,991 A-371-Of-International US9018010B2 (en) 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
US14/696,520 Continuation US10876094B2 (en) 2009-11-12 2015-04-27 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state

Publications (2)

Publication Number Publication Date
WO2011058558A2 WO2011058558A2 (en) 2011-05-19
WO2011058558A3 true WO2011058558A3 (en) 2011-10-13

Family

ID=43992162

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2010/000937 WO2011058558A2 (en) 2009-11-12 2010-11-11 Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state

Country Status (8)

Country Link
US (4) US9018010B2 (en)
EP (3) EP4166652A1 (en)
JP (5) JP6276918B2 (en)
CA (3) CA3080762A1 (en)
DK (2) DK2499236T3 (en)
ES (2) ES2779048T3 (en)
IL (1) IL252607B (en)
WO (1) WO2011058558A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3080762A1 (en) 2009-11-12 2011-05-19 Technion Research & Development Foundation Limited Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
CN107189979B (en) 2010-03-01 2021-05-04 詹森生物科技公司 Method for purifying cells derived from pluripotent stem cells
BR112013002811A8 (en) 2010-08-05 2020-01-28 Wisconsin Alumni Res Found simplified basic means for human pluripotent cell culture
US9279107B2 (en) 2010-08-05 2016-03-08 Wisconsin Alumni Research Foundation Simplified basic media for human pluripotent cell culture
DK2614141T3 (en) 2010-09-07 2019-09-09 Technion Res & Dev Foundation PRESENT PROCEDURES AND CULTIVATION MEDIA FOR CULTURING PLURIPOTENT STEM CELLS
GB201117469D0 (en) * 2011-10-10 2011-11-23 Cell Guidance Systems Ltd Culture media for pluripotent stem cells
JP6466170B2 (en) * 2011-10-17 2019-02-06 ミネルバ バイオテクノロジーズ コーポレーション Medium for stem cell growth and induction
JP5999658B2 (en) 2011-11-25 2016-09-28 国立大学法人京都大学 Method for culturing pluripotent stem cells
EP2788033B1 (en) 2011-12-05 2017-05-31 Factor Bioscience Inc. Methods and products for transfecting cells
RU2668798C2 (en) 2011-12-22 2018-10-02 Янссен Байотек, Инк. Methods for in vitro of step-by-step differentiation of pluripotent cells
RU2668814C2 (en) * 2012-05-07 2018-10-02 Янссен Байотек, Инк. Methods of producing cells of definitive and pancreatic endoderm
RU2018108090A (en) 2012-12-31 2019-02-25 Янссен Байотек, Инк. SUSPENDING AND CLUSTERING OF HUMAN PLURIPOTENT CELLS FOR THEIR DIFFERENTIATION IN PANCREATIC ENDOCRINE CELLS
RU2658488C2 (en) 2012-12-31 2018-06-21 Янссен Байотек, Инк. Method for obtaining cells expressing markers characteristic for pancreatic endocrine cells
US10370644B2 (en) 2012-12-31 2019-08-06 Janssen Biotech, Inc. Method for making human pluripotent suspension cultures and cells derived therefrom
US9738861B2 (en) 2013-03-06 2017-08-22 Kyoto University Culture system for pluripotent stem cells and method for subculturing pluripotent stem cells
EP3008172B1 (en) 2013-06-11 2020-05-06 Ncardia B.V. Culture medium compositions for maturating cardiomyocytes derived from pluripotent mammalian stem cells
EP3015551B1 (en) * 2013-06-28 2019-03-06 Kaneka Corporation Method for screening for pluripotent stem cell growth-promoting factor
WO2015037622A1 (en) * 2013-09-10 2015-03-19 富士フイルム株式会社 Culture method for pluripotent stem cells, culture kit, and medium for pluripotent stem cell culture
CN105637086B (en) * 2013-09-10 2019-07-12 富士胶片株式会社 The culture kit and culture medium of multipotential stem cell used in the cultural method of multipotential stem cell, this method
WO2015098111A1 (en) * 2013-12-26 2015-07-02 国立大学法人広島大学 METHOD FOR ESTABLISHING iPS CELLS AND METHOD FOR LONG-TERM MAINTENANCE OF STEM CELLS
JP6516280B2 (en) * 2013-12-26 2019-05-22 国立大学法人広島大学 Method for establishing iPS cells and method for long-term maintenance of stem cells
EP3604499A1 (en) * 2014-03-04 2020-02-05 Fate Therapeutics, Inc. Improved reprogramming methods and cell culture platforms
KR20160147800A (en) * 2014-05-06 2016-12-23 에프. 호프만-라 로슈 아게 Method for differentiation of pluripotent stem cells into cardiomyocytes
US20150335010A1 (en) 2014-05-21 2015-11-26 Bourbon Corporation Maintenance medium for primate pluripotent stem cells
CN104388382B (en) * 2014-11-21 2017-05-10 吉林大学 Method for rapidly preparing Feeder cells by using stirring-type cell culturing bottle rolling machine
US9944894B2 (en) 2015-01-16 2018-04-17 General Electric Company Pluripotent stem cell expansion and passage using a rocking platform bioreactor
CN108138130A (en) * 2015-08-31 2018-06-08 爱平世股份有限公司 The method of multipotential stem cell manufacture system and production induced multi-potent stem cell
CA3001917A1 (en) 2015-10-16 2017-04-20 Fate Therapeutics, Inc. Platform for the induction & maintenance of ground state pluripotency
CA3030252A1 (en) * 2016-07-19 2018-01-25 Accellta Ltd. Culture media for culturing pluripotent stem cells in suspension
WO2018029656A2 (en) * 2016-08-12 2018-02-15 The University Of Chicago Methods for making and using therapeutic exosomes
JP6647545B2 (en) * 2017-05-02 2020-02-14 剛士 田邊 Pharmaceutical and cosmetic compositions
EP3770249A4 (en) * 2018-03-20 2021-04-21 FUJIFILM Corporation Method for three-dimensionally culturing pluripotent stem cells
KR102482097B1 (en) * 2019-12-09 2022-12-29 주식회사 대웅제약 Method for Preparing Mesenchymal Stem Cells from Human Pluripotent Stem Cells and Mesenchymal Stem Cells Prepared by Thereof
WO2021145319A1 (en) * 2020-01-14 2021-07-22 味の素株式会社 Cell culture medium composition
CN111484970B (en) * 2020-04-30 2022-09-16 广州再生医学与健康广东省实验室 Serum-free and feeder-layer-free embryo and pluripotent stem cell culture medium with low protein content
CN117795057A (en) * 2021-06-09 2024-03-29 艾策尔塔公司 Serum-free medium for suspension culture of pluripotent stem cells of mammalian livestock
US11735303B2 (en) 2021-06-22 2023-08-22 David Haase Apparatus and method for determining a composition of a replacement therapy treatment
CN113403262A (en) * 2021-06-23 2021-09-17 昆明理工大学 Layer-free culture method for stem cells of cynomolgus monkeys
WO2023053220A1 (en) * 2021-09-28 2023-04-06 公益財団法人京都大学ｉＰＳ細胞研究財団 Method for producing pluripotent stem cells
WO2024030501A2 (en) * 2022-08-02 2024-02-08 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Bovine trophoblast stem cells and uses thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050233446A1 (en) * 2003-12-31 2005-10-20 Parsons Xuejun H Defined media for stem cell culture
WO2008015682A2 (en) * 2006-08-02 2008-02-07 Technion Research & Development Foundation Ltd. Methods of expanding embryonic stem cells in a suspension culture
US20090191159A1 (en) * 2007-06-15 2009-07-30 Kazuhiro Sakurada Multipotent/pluripotent cells and methods

Family Cites Families (190)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (en) 1971-02-10 1977-09-15 Organon Nv METHOD FOR THE DETERMINATION AND DETERMINATION OF SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES.
NL154598B (en) 1970-11-10 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
NL154599B (en) 1970-12-28 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (en) 1972-05-11 1983-06-01 Akzo Nv METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
IL68218A (en) 1983-03-23 1985-12-31 Univ Ramot Compositions for cartilage repair comprising embryonal chondrocytes
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US5489304A (en) 1994-04-19 1996-02-06 Brigham & Women's Hospital Method of skin regeneration using a collagen-glycosaminoglycan matrix and cultured epithelial autograft
US5843780A (en) 1995-01-20 1998-12-01 Wisconsin Alumni Research Foundation Primate embryonic stem cells
US7410773B2 (en) 1995-02-02 2008-08-12 Ghazi Jaswinder Dhoot Method of preparing an undifferentiated cell
AU7243100A (en) 1995-02-02 2001-05-03 Tristem Trading (Cyprus) Limited A method of preparing an undifferentiated cell
JPH08308561A (en) * 1995-05-16 1996-11-26 Sumitomo Electric Ind Ltd Serum-free medium for animal cell culture
US5811297A (en) 1996-03-07 1998-09-22 Amba Biosciences, Llc Immortalized hematopoietic cell lines, cell system thereof with stromal cells, in vitro, ex vivo and in vivo uses, & in vitro generation of dendritic cells and macrophages
JP4307552B2 (en) 1996-03-15 2009-08-05 ミューニン コーポレイション Extracellular matrix signaling molecules
US6878544B2 (en) 1996-04-19 2005-04-12 Neurotech Sa Retinal cell lines with extended life-span and their applications
EP0986635A4 (en) 1997-01-10 2001-11-07 Life Technologies Inc Embryonic stem cell serum replacement
US6090622A (en) 1997-03-31 2000-07-18 The Johns Hopkins School Of Medicine Human embryonic pluripotent germ cells
US6331406B1 (en) 1997-03-31 2001-12-18 The John Hopkins University School Of Medicine Human enbryonic germ cell and methods of use
AU8284198A (en) 1997-07-02 1999-01-25 Board Of Regents, The University Of Texas System P53 as a regulator of cell differentiation
IL122818A0 (en) 1997-07-10 1998-08-16 Yeda Res & Dev Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof
AU1197699A (en) 1997-10-23 1999-05-10 Geron Corporation Methods and materials for the growth of primate-derived primordial stem cells
US7410798B2 (en) 2001-01-10 2008-08-12 Geron Corporation Culture system for rapid expansion of human embryonic stem cells
US7413904B2 (en) 1998-10-23 2008-08-19 Geron Corporation Human embryonic stem cells having genetic modifications
US6667176B1 (en) 2000-01-11 2003-12-23 Geron Corporation cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
WO2000027995A1 (en) 1998-11-09 2000-05-18 Monash University Embryonic stem cells
IL142914A0 (en) * 1998-11-09 2002-04-21 Consorzio Per La Gestione Del Serum free medium for chondrocyte-like cells
US20030129745A1 (en) 1999-10-28 2003-07-10 Robl James M. Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
US7455983B2 (en) 2000-01-11 2008-11-25 Geron Corporation Medium for growing human embryonic stem cells
JP2001229797A (en) 2000-02-15 2001-08-24 Yazaki Corp Gas type breaker for source circuit
WO2001068815A1 (en) 2000-03-14 2001-09-20 Es Cell International Pte Ltd Embryonic stem cells and neural progenitor cells derived therefrom
AU2001244354A1 (en) 2000-03-30 2001-10-15 Oxford Biomedica (Uk) Limited Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for thetreatment of neurological disorders
US7473555B2 (en) 2000-04-27 2009-01-06 Geron Corporation Protocols for making hepatocytes from embryonic stem cells
NL1017973C2 (en) 2000-05-10 2002-11-08 Tristem Trading Cyprus Ltd Design.
US7250294B2 (en) 2000-05-17 2007-07-31 Geron Corporation Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
CN100580079C (en) 2000-05-17 2010-01-13 杰龙公司 Neural progenitor cell populations
US20020090722A1 (en) 2000-06-15 2002-07-11 Tanja Dominko Pluripotent mammalian cells
GB0025088D0 (en) 2000-10-13 2000-11-29 Univ Edinburgh Stem cells
US6576464B2 (en) 2000-11-27 2003-06-10 Geron Corporation Methods for providing differentiated stem cells
CA2430653A1 (en) 2000-11-27 2002-08-08 Yissum Research Development Company Of The Hebrew University In Jerusalem Transfection of human embryonic stem cells
JP2004532648A (en) 2000-11-30 2004-10-28 ステムロン インコーポレイテッド Isolated homozygous stem cells, differentiated cells derived therefrom, and materials and methods for making and using the same
CA2447015A1 (en) 2001-05-15 2002-11-21 Rappaport Family Institute For Research In The Medical Sciences Insulin producing cells derived from human embryonic stem cells
CN101029302B (en) 2001-06-21 2011-03-30 杰龙公司 Dopaminergic neurons and proliferation-competent precursor cells for treating parkinson's disease
CN1636054A (en) 2001-07-06 2005-07-06 杰龙公司 Mesenchymal cells and osteoblasts from human embryonic stem cell
JP2004535199A (en) 2001-07-12 2004-11-25 ジェロン コーポレイション Cardiomyocyte lineage cells produced from human pluripotent stem cells
AU2002317039B2 (en) 2001-07-24 2007-10-04 Es Cell International Pte Ltd Methods of inducing differentiation of stem cells
US7432104B2 (en) 2001-08-06 2008-10-07 Bresgen Inc. Methods for the culture of human embryonic stem cells on human feeder cells
US20030211603A1 (en) 2001-08-14 2003-11-13 Earp David J. Reprogramming cells for enhanced differentiation capacity using pluripotent stem cells
WO2003018780A1 (en) 2001-08-27 2003-03-06 Advanced Cell Technology, Inc. De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies
WO2003023018A2 (en) 2001-09-12 2003-03-20 DeveloGen Aktiengesellschaft für entwicklungsbiologische Forschung A method for isolating, culturing and differentiating intestinal stem cells for therapeutic use
US20050095708A1 (en) 2001-11-09 2005-05-05 Pera Martin F. Characterization and isolation of subsets of human embryonic stem cells (HES) and cells associated or derived therefrom
WO2003050251A2 (en) 2001-12-07 2003-06-19 Geron Corporation Hematopoietic cells from human embryonic stem cells
CN101240262A (en) 2001-12-07 2008-08-13 杰龙公司 Islet cells from human embryonic stem cells
AU2002366602B2 (en) 2001-12-07 2008-07-03 Asterias Biotherapeutics, Inc. Chondrocyte precursors derived from human embryonic stem cells
AU2002357410A1 (en) 2001-12-21 2003-07-09 Thromb-X Nv Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells
US20050095703A1 (en) 2001-12-28 2005-05-05 Henrik Semb Method for the establishment of a pluripotent human blastocyst - derived stem cell line
AU2009213101B2 (en) 2002-06-05 2012-03-08 Es Cell International Pte Ltd Generation of neural stem cells from undifferentiated human embryonic stem cells
WO2003104423A2 (en) 2002-06-11 2003-12-18 Roy Ogle Meningeal-derived stem cells
US7662625B2 (en) 2002-07-02 2010-02-16 Cancer Research Technology Limited Methods for detecting the differentiation status of cells using 5T4 antigen expression
US7285415B2 (en) 2002-07-11 2007-10-23 The Regents Of The University Of California Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US20050101014A1 (en) 2002-07-11 2005-05-12 Keirstead Hans S. Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
US7267981B2 (en) 2002-10-07 2007-09-11 Technion Research & Development Foundation Ltd. Human foreskin fibroblasts for culturing ES cells
US20060252150A1 (en) 2002-11-08 2006-11-09 Linzhao Cheng Human embryonic stem cell cultures, and compositions and methods for growing same
US20040110286A1 (en) 2002-12-06 2004-06-10 The John P. Robarts Research Institute Method for making hematopoietic cells
SI1572984T1 (en) 2002-12-16 2016-07-29 Technion Research & Development Foundation Ltd. Feeder-free, xeno-free culture system for human embryonic stem cells
WO2004078944A2 (en) 2003-03-05 2004-09-16 Maine Medical Center Research Institute Thrombin, soluble jaggedi, and trap and growth of stem cells
US20060134636A1 (en) 2003-03-13 2006-06-22 Stanton Lawrence W Standardization of growth conditions for human embryonic stem cells intended for use in regenerative medicine
US7153650B2 (en) 2003-03-13 2006-12-26 Geron Corporation Marker system for preparing and characterizing high-quality human embryonic stem cells
US20030224411A1 (en) 2003-03-13 2003-12-04 Stanton Lawrence W. Genes that are up- or down-regulated during differentiation of human embryonic stem cells
WO2004085631A2 (en) 2003-03-28 2004-10-07 Mount Sinai Hospital Canine embryonic stem cells
US7638328B2 (en) 2003-05-08 2009-12-29 Cellartis Ab Method for efficient transfer of human blastocyst-derived stem cells (hBS cells) from a feeder-supported to a feeder-free culture system, long-term propagation of hBS cells under feeder-free conditions and use of cultured hBS cells for applications in myocardial regeneration
US20040229350A1 (en) 2003-05-12 2004-11-18 Nikolai Strelchenko Morula derived embryonic stem cells
US20050118713A1 (en) 2003-05-12 2005-06-02 Nikolai Strelchenko Morula derived embryonic stem cells
US7569385B2 (en) 2003-08-14 2009-08-04 The Regents Of The University Of California Multipotent amniotic fetal stem cells
CA2549158A1 (en) 2003-12-01 2005-06-16 Technion Research And Development Foundation Ltd. Methods of generating stem cells and embryonic bodies carrying disease-causing mutations and methods of using same for studying genetic disorders
TWI280280B (en) 2003-12-09 2007-05-01 Ind Tech Res Inst Culture system and method for expansion and undifferentiated growth of human embryonic stem cells
GB2441530B (en) 2004-02-12 2009-09-23 Univ Newcastle Stem Cells
US20060216821A1 (en) 2004-02-26 2006-09-28 Reliance Life Sciences Pvt. Ltd. Pluripotent embryonic-like stem cells derived from corneal limbus, methods of isolation and uses thereof
WO2005086845A2 (en) 2004-03-10 2005-09-22 Regents Of The University Of California Compositions and methods for growth of embryonic stem cells
IL178006A (en) 2004-03-19 2011-08-31 Geron Corp Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
CN1969040B (en) 2004-03-19 2014-12-10 阿斯特利亚斯生物治疗股份公司 Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
RU2375448C2 (en) 2004-03-23 2009-12-10 Асубио Фарма Ко., Лтд. Method of cultivation pluripotential stem cells
US7452718B2 (en) 2004-03-26 2008-11-18 Geron Corporation Direct differentiation method for making cardiomyocytes from human embryonic stem cells
US20050214938A1 (en) 2004-03-26 2005-09-29 Gold Joseph D Cardiac bodies: clusters of spontaneously contracting cells for regenerating cardiac function
US20050227352A1 (en) 2004-04-09 2005-10-13 Stowers Institute For Medical Research Use of BMP (BAM) signaling to control stem cell fate determination
WO2005113747A2 (en) 2004-05-21 2005-12-01 Fraunhofer Gesellschaft zur Förderung der angewandten Forschung e.V. Multicellular tissue and organ culture systems
EP1749091B1 (en) 2004-05-21 2013-07-31 Wicell Research Institute, Inc. Feeder independent extended culture of embryonic stem cells
US20080038820A1 (en) 2004-06-22 2008-02-14 Rudy-Reil Diane E Induction of pluripotent stem cells into mesodermal lineages
US20090136559A1 (en) 2004-07-09 2009-05-28 Athanasiou Kyriacos A Chondrocyte Differentiation from Human Embryonic Stem Cells and Their Use in Tissue Engineering
AU2005271723B2 (en) 2004-07-13 2010-12-16 Asterias Biotherapeutics, Inc. Medium for growing human embryonic stem cells
CA2504451A1 (en) 2004-08-10 2006-02-10 Geron Corporation Dendritic cell vaccines for treating cancer made from embryonic stem cells
US20080311607A1 (en) 2004-08-12 2008-12-18 Board Of Regents Of The University Of Texas System Methods and Compositions for Regulation of Stem Cell Survival, Proliferation, and Differentiation by Protein Ubiquitination
DE102004043256B4 (en) 2004-09-07 2013-09-19 Rheinische Friedrich-Wilhelms-Universität Bonn Scalable process for culturing undifferentiated stem cells in suspension
NZ553235A (en) 2004-09-08 2009-11-27 Wisconsin Alumni Res Found Culturing human pluripotent stem cells
CA2580754A1 (en) 2004-09-21 2006-03-30 Nvr Labs, Ltd. Compositions and methods for stem cell expansion and differentiation
WO2006040763A2 (en) 2004-10-12 2006-04-20 Technion Research & Development Foundation Ltd. Isolated primate embryonic cells and methods of generating and using same
JP4646600B2 (en) * 2004-11-02 2011-03-09 オリンパス株式会社 Method for culturing mesenchymal stem cells
US7641897B2 (en) 2004-11-23 2010-01-05 The Board Of Trustees Of The Leland Stanford Junior University Feeder layer and serum independent embryonic stem cells
FR2878860A1 (en) 2004-12-08 2006-06-09 Vivalis Sa HUMAN STEM CELL LINES DERIVED FROM ES CELLS AND USES FOR THE PRODUCTION OF RECOMBINANT VACCINES AND PROTEINS
US8597947B2 (en) 2004-12-29 2013-12-03 Hadasit Medical Research Services & Development Limited Undifferentiated stem cell culture systems
EP2410043A3 (en) 2004-12-29 2013-01-23 Hadasit Medical Research Services And Development Ltd. Stem cells culture systems
GB2437689B (en) 2005-01-28 2009-10-28 Novathera Ltd Culture and screening methods
WO2006088867A2 (en) 2005-02-15 2006-08-24 Medistem Laboratories, Incorporated Method for expansion of stem cells
RU2007135164A (en) 2005-02-23 2009-03-27 Эйдженси Фор Сайенс, Текнолоджи Энд Рисерч (Sg) IMMORTALIZED FEEDER CELLS
US8012751B2 (en) 2005-03-31 2011-09-06 Wisconsin Alumni Research Foundation Differentiation of pluripotent embryonic stem cells
US7972767B2 (en) 2005-05-09 2011-07-05 Olympus Corporation Method for culturing mesenchymal stem cell and method for producing biological tissue prosthesis
JP4755460B2 (en) * 2005-07-27 2011-08-24 オリンパス株式会社 Method for culturing mesenchymal stem cells
US9446073B2 (en) 2005-05-15 2016-09-20 Biodontos, Llc Non-lineage committed precursor cells from the dental papillary tissue of teeth
BRPI0612423A2 (en) 2005-05-17 2009-01-27 Reliance Life Sciences Pvt Ltd pedigree establishment of human embryonic stem cells using mammalian cells
US20110311977A1 (en) 2005-05-17 2011-12-22 Arundhati Mandal In Vitro Generation of Hepatocytes from Human Embryonic Stem Cells
WO2007002210A2 (en) 2005-06-20 2007-01-04 Bresagen, Inc. Embryonic stem cell culture compositions and methods of use thereof
WO2007002086A2 (en) 2005-06-22 2007-01-04 Geron Corporation Suspension culture of human embryonic stem cells
CA2615396A1 (en) * 2005-07-15 2007-01-25 Primegen Biotech, Llc Therapeutic reprogramming of germ line stem cells
EP1962719A4 (en) 2005-08-29 2011-05-04 Technion Res And Dev Of Foundation Ltd Media for culturing stem cells
US7754483B2 (en) 2005-11-09 2010-07-13 The Penn State Research Foundation Systems and methods for selection and maintenance of homogeneous and pluripotent human embryonic stem cells
US20080070303A1 (en) 2005-11-21 2008-03-20 West Michael D Methods to accelerate the isolation of novel cell strains from pluripotent stem cells and cells obtained thereby
EA018039B1 (en) 2005-12-13 2013-05-30 Киото Юниверсити Nuclear reprogramming factor
US20070249044A1 (en) 2006-01-30 2007-10-25 University Of Illinois At Chicago Microstructures in three dimensional gel suspensions for growth of cells
US9115342B2 (en) 2006-01-31 2015-08-25 Daiichi Sankyo Company Method for purifying cardiomyocytes or programmed cardiomyocytes derived from stem cells or fetuses
SG10201405107YA (en) 2006-02-23 2014-10-30 Viacyte Inc Compositions and methods useful for culturing differentiable cells
JP2007228815A (en) 2006-02-27 2007-09-13 Gifu Univ Method for maintaining embryonic stem cell
WO2007122233A1 (en) 2006-04-25 2007-11-01 Vrije Universiteit Brussel Preparation of mesenchymal progenitor cells, particularly osteogenic progenitor cells
US8241908B2 (en) 2006-05-16 2012-08-14 Becton, Dickinson And Company Extracellular matrix coated surface for culturing cells
US9096831B2 (en) 2006-05-19 2015-08-04 Versitech Limited Methods to enhance cell migration and engraftment
GB0613756D0 (en) * 2006-07-12 2006-08-23 Univ Sheffield Cell culture medium
US20100069251A1 (en) 2006-09-15 2010-03-18 Children's Medical Center Corporation Methods for producing embryonic stem cells from parthenogenetic embryos
WO2008054819A2 (en) 2006-11-02 2008-05-08 The General Hospital Corporation Cardiovascular stem cells, methods for stem cell isolation, and uses thereof
WO2008058942A2 (en) 2006-11-13 2008-05-22 Charite - Universitätsmedezin Berlin Method of cell culture and method of treatment comprising a vepo protein variant
US8414928B2 (en) 2006-12-06 2013-04-09 George R. Dodge Methods for the generation of cartilage-like material by mechanical loading
WO2008075378A2 (en) 2006-12-19 2008-06-26 Stempeutics Research Private Limited Xeno-free culture conditions for human embryonic stem cells and methods thereof
US20080182328A1 (en) 2006-12-19 2008-07-31 The Burnham Institute Mammalian extraembryonic endoderm cells and methods of isolation
CN101605885B (en) 2007-01-04 2013-03-27 卡尔·特吕格瓦松 Composition and method for enabling proliferation of pluripotent stem cells
US10829733B2 (en) 2007-01-04 2020-11-10 Biolamina Ab Composition and method for enabling proliferation of pluripotent human stem cells
GB2458863B (en) 2007-01-17 2011-10-12 Wisconsin Alumni Res Found Improved culture of stem cells
WO2008087257A1 (en) 2007-01-18 2008-07-24 Suomen Punainen Risti, Veripalvelu Novel methods and reagents directed to production of cells
US20110033928A1 (en) 2007-03-09 2011-02-10 The Regents Of The University Of Michigan Methods and compositions for growth of cells and embryonic tissue on a synthetic polymer matrix
DE102007020302B4 (en) 2007-04-20 2012-03-22 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Improved three-dimensional biocompatible scaffold structure that incorporates nanoparticles
WO2008148105A1 (en) 2007-05-25 2008-12-04 Medistem Laboratories, Inc. Endometrial stem cells and methods of making and using same
FI20075417A0 (en) * 2007-06-05 2007-06-05 Marjo-Riitta Suuronen Formulations and methods for culturing embryonic stem cells
DK2173863T3 (en) 2007-06-29 2019-01-21 Fujifilm Cellular Dynamics Inc Automated method and apparatus for embryonic stem cell culture
EP2028268A1 (en) 2007-08-20 2009-02-25 Université Libre De Bruxelles Generation of neuronal cells from pluripotent stem cells
EP2191022A2 (en) 2007-08-21 2010-06-02 The Salk Institute for Biological Studies Robust regression based exon array protocol system and applications
US8623650B2 (en) 2007-10-19 2014-01-07 Viacyte, Inc. Methods and compositions for feeder-free pluripotent stem cell media containing human serum
EP2072618A1 (en) 2007-12-14 2009-06-24 Johannes Gutenberg-Universität Mainz Use of RNA for reprogramming somatic cells
CA2709566A1 (en) 2007-12-17 2009-06-25 Gliamed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
JP2011510658A (en) * 2008-01-30 2011-04-07 ジェロン・コーポレーション Synthetic surface for culturing stem cell-derived cardiomyocytes
BRPI0906724A2 (en) 2008-01-30 2019-05-07 Geron Corp cell culture article and screening
CA2725251A1 (en) 2008-05-27 2009-12-17 Aarhus Universitet Biocompatible materials for mammalian stem cell growth and differentiation
US20100120142A1 (en) 2008-07-11 2010-05-13 Suomen Punainen Risti Veripalvelu Culture of human embryonic cells
US20100035327A1 (en) 2008-08-11 2010-02-11 Ann Marie Steele Use of rice-derived products in a universal cell culture medium
SG160248A1 (en) 2008-09-18 2010-04-29 Agency Science Tech & Res Use of novel monoclonal antibodies targeting human embryonic stem cells to characterize and kill induced pluripotent stem cells
US8895300B2 (en) 2008-11-04 2014-11-25 Viacyte, Inc. Scalable primate pluripotent stem cell aggregate suspension culture and differentiation thereof
US8008075B2 (en) 2008-11-04 2011-08-30 Viacyte, Inc. Stem cell aggregate suspension compositions and methods of differentiation thereof
US8956867B2 (en) 2008-11-07 2015-02-17 Wisconsin Alumni Research Foundation Method for culturing stem cells
KR101720961B1 (en) 2009-02-27 2017-03-29 셀룰러 다이내믹스 인터내셔널, 인코포레이티드 Differentiation of pluripotent cells
CN102741396B (en) 2009-04-27 2017-10-20 威盛细胞有限公司 Support the small molecule and its method of pluripotent cell growth
US20120142103A1 (en) 2009-05-18 2012-06-07 Kohji Nishida Method for inducing differentiation into epithelial progenitor cell/stem cell population and corneal epithelial cell population from induced pluripotent stem cells
JP2012529890A (en) 2009-06-11 2012-11-29 ミネルバ バイオテクノロジーズ コーポレーション Method for culturing stem cells and progenitor cells
TW201111328A (en) 2009-06-12 2011-04-01 Nanyang Polytechnic Novel uses
KR101166257B1 (en) 2009-06-16 2012-07-19 한국생명공학연구원 Media composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
WO2011019953A1 (en) 2009-08-12 2011-02-17 University Of Southern California Defined conditions for human embryonic stem cell culture and passage
US8415155B2 (en) 2009-10-19 2013-04-09 Cellular Dynamics International, Inc. Cardiomyocyte production
CA3080762A1 (en) 2009-11-12 2011-05-19 Technion Research & Development Foundation Limited Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
KR20120102709A (en) 2009-11-17 2012-09-18 어드밴스드 셀 테크놀로지, 인코포레이티드 Methods of producing human rpe cells and pharmaceutical preparations of human rpe cells
EP2512516B1 (en) 2009-12-18 2016-02-17 The Governing Council Of The University Of Toronto Injectable polymer composition for use as a cell delivery vehicle
US8609416B2 (en) 2009-12-18 2013-12-17 Ventria Bioscience Methods and compositions comprising heat shock proteins
US20140030236A1 (en) 2010-02-25 2014-01-30 The Johns Hopkins University Derivation and maturation of synthetic and contractile vascular smooth muscle cells from human pluripotent stem cells
WO2011110886A1 (en) 2010-03-09 2011-09-15 Biolamina Ab Composition and method for enabling proliferation of pluripotent human stem cells
EP2561087A4 (en) 2010-04-20 2013-10-16 Int Stem Cell Corp Physiological methods for isolation of high purity cell populations
WO2011140397A2 (en) 2010-05-05 2011-11-10 The Regents Of The University Of California Office Of The President Stem cell defined media for xeno-free and feeder free conditions and uses thereof
US11786636B2 (en) 2010-06-15 2023-10-17 Versitech Limited Methods for complex tissue engineering
WO2011160128A2 (en) 2010-06-18 2011-12-22 Cellular Dynamics International, Inc. Cardiomyocyte medium with dialyzed serum
PL2596119T3 (en) 2010-07-23 2021-12-06 Astellas Institute For Regenerative Medicine Methods for detection of rare subpopulations of cells and highly purified compositions of cells
US20120141432A1 (en) 2010-09-03 2012-06-07 University Of Pittsburgh- Of The Commonwealth System Of Higher Education Use of catalytic antioxidant to preserve stem cell phenotype and control cell differentiation
DK2614141T3 (en) 2010-09-07 2019-09-09 Technion Res & Dev Foundation PRESENT PROCEDURES AND CULTIVATION MEDIA FOR CULTURING PLURIPOTENT STEM CELLS
WO2012034101A2 (en) 2010-09-09 2012-03-15 The Regents Of The University Of California Expandable cell source of neuronal stem cell populations and methods for obtaining and using them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050233446A1 (en) * 2003-12-31 2005-10-20 Parsons Xuejun H Defined media for stem cell culture
WO2008015682A2 (en) * 2006-08-02 2008-02-07 Technion Research & Development Foundation Ltd. Methods of expanding embryonic stem cells in a suspension culture
US20090191159A1 (en) * 2007-06-15 2009-07-30 Kazuhiro Sakurada Multipotent/pluripotent cells and methods

Also Published As

Publication number Publication date
JP2020022480A (en) 2020-02-13
CA2783437A1 (en) 2011-05-19
JP2013510567A (en) 2013-03-28
IL252607B (en) 2019-02-28
CA3080762A1 (en) 2011-05-19
DK3633025T3 (en) 2022-12-12
EP3633025A1 (en) 2020-04-08
CA3174901A1 (en) 2011-05-19
CA2783437C (en) 2020-08-04
WO2011058558A2 (en) 2011-05-19
US20150240202A1 (en) 2015-08-27
ES2932664T3 (en) 2023-01-23
US10876094B2 (en) 2020-12-29
JP6276918B2 (en) 2018-02-07
EP4166652A1 (en) 2023-04-19
JP6603694B2 (en) 2019-11-06
JP2017225456A (en) 2017-12-28
IL252607A0 (en) 2017-07-31
EP2499236A2 (en) 2012-09-19
EP2499236A4 (en) 2013-05-22
JP2022088599A (en) 2022-06-14
US9018010B2 (en) 2015-04-28
EP2499236B1 (en) 2020-01-01
JP7383069B2 (en) 2023-11-17
US20120225480A1 (en) 2012-09-06
JP2016047056A (en) 2016-04-07
JP7053551B2 (en) 2022-04-12
DK2499236T3 (en) 2020-03-23
EP3633025B1 (en) 2022-09-14
ES2779048T3 (en) 2020-08-13
US20210079342A1 (en) 2021-03-18
US20220333066A1 (en) 2022-10-20

Similar Documents

Publication Publication Date Title
WO2011058558A3 (en) Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
WO2011159359A3 (en) Serum-free chemically defined cell culture medium
AU2019268194A1 (en) Cell culture system
JP2013510567A5 (en)
SG150567A1 (en) Pluripotent stem cell growing method
WO2012032521A3 (en) Novel methods and culture media for culturing pluripotent stem cells
WO2008004990A3 (en) Method for stem cell culture and cells derived therefrom
MX343462B (en) Cell culture medium.
WO2008129563A3 (en) Human mesenchymal stem cells and preparation thereof
WO2007115337A3 (en) Chondrocyte differentiation from human embryonic stem cells and their use in tissue engineering
WO2011005773A3 (en) Method of culturing eukaryotic cells
WO2010147395A3 (en) Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
CA2863795A1 (en) Culturing of mesenchymal stem cells
EP4223769A3 (en) Nuclear reprogramming factor
WO2004055155A3 (en) Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
EP1789534A4 (en) Isolation of stem/progenitor cells from amniotic membrane of umbilical cord.
RU2011124900A (en) CULTURE OF PLURIPOTENT STEM CELLS ON MICRO-CARRIERS
WO2007088372A3 (en) Cell culture
WO2006070370A3 (en) Stem cells culture systems
RU2016121404A (en) SUSPENDING AND CLUSTERING OF HUMAN PLURIPOTENT STEM CELLS WITH THE PURPOSE OF THEIR DIFFERENTIATION IN PANCREATIC ENDOCRINE CELLS
WO2008120218A3 (en) Undifferentiated stem cell culture systems
WO2012034101A3 (en) Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
WO2008152640A3 (en) Three dimensional biocompatible scaffolds for ex-vivo expansion and transplantation of stem cells
WO2005094353A3 (en) Methods for production of regulatory t cells and uses thereof
SG179458A1 (en) Growth medium for c. histolyticum without ingredients of mamalian sources

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10829622

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2783437

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 219736

Country of ref document: IL

Ref document number: 13508991

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2012538468

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 2010829622

Country of ref document: EP